Likes	Subject	Older
	MRK 4Q22 results—2023 guidance:		DewDiligence	02/02/23 8:10 AM
	FDA approves Keytruda for adjuvant NSCLC following adjuvant		DewDiligence	01/27/23 10:25 AM
	That would be the best , most productive		extrooper	01/27/23 8:18 AM
	Keytruda fails again in prostate cancer—one of the		DewDiligence	01/25/23 1:29 PM
	Why		Pattyloco	12/29/22 10:02 AM
	The MRK-SGEN deal reputed to be nearly done		DewDiligence	12/22/22 11:14 AM
	MRK/MRNA cancer vaccine shines in adjuvant melanoma (RFS HR=0.56):		DewDiligence	12/13/22 9:59 AM
	MRK acquires IMGO for $36.00/sh cash—a 107% premium		DewDiligence	11/21/22 8:36 AM
	I would take the other side of that bet!		DewDiligence	11/18/22 3:44 PM
	Ehhhhh seems a lot more likely today		Pattyloco	11/18/22 3:44 PM
	Unlikely, haha.		DewDiligence	11/18/22 3:43 PM
	NWBO next purchase of Merck?		Pattyloco	11/18/22 3:36 PM
	MRK 3Q22 CC slides:		DewDiligence	10/27/22 12:26 PM
	MRK 3Q22 results:		DewDiligence	10/27/22 9:25 AM
	MRK exercises option_to_commercialize MRNA cancer vaccine:		DewDiligence	10/12/22 11:26 AM
	Sotatercept phase-3 in PAH hits primary endpoint:		DewDiligence	10/10/22 12:23 PM
	Lagevrio misses_primary_endpoint_in_large_Oxford_U_trial:		DewDiligence	10/06/22 8:28 PM
	FDA allows some Islatravir trials to_resume_at_a lower dose:		DewDiligence	09/20/22 9:22 AM
	Keytruda narrowly_misses_statsig OS/PFS as_addend_to Lenvina in_ first-line HCC:		DewDiligence	09/10/22 3:00 PM
	Merck snatched up ROR1 veslobio for 2.75 Billion		TechandBio	08/18/22 8:37 AM
	Keytruda fails phase-3 in CRPC:		DewDiligence	08/03/22 11:59 AM
	FDA approves MRK’s pneumococcal vaccine, Vaxneuvance for infants/children:		DewDiligence	06/22/22 7:22 AM
	WHAT ARE YOU TALKING ABOUT??? COVID-19 IS		Agoura Guy	06/18/22 8:17 PM
	Pay attention, looks like we have a change		Lowjack	06/18/22 7:31 PM
	MRK slides from ASCO webcast:		DewDiligence	06/07/22 12:15 PM
	Synopsis of (anti-LAG-3) favezelimab data from ASCO abstract:		DewDiligence	05/26/22 6:39 PM
	MRK 1Q22 results:		DewDiligence	04/28/22 8:54 AM
	CHMP approves Keytruda/chemo in the neoadjuvant setting followed		DewDiligence	04/25/22 10:32 AM
	MRK’s V116—(follow-on_to Vaxneuvance)—receives FDA BTD for prevention of		DewDiligence	04/14/22 9:59 AM
	MRK—Vaxneuvance sBLA for pediatrics gets 3-month extension to 7/1/22:		DewDiligence	04/01/22 10:28 AM
	FDA approves Keytruda monotherapy for recurrent endometrial cancer		DewDiligence	03/21/22 5:47 PM
	Thanks DewDiligence. The reason I ask, is that		Just the facts maam	03/20/22 6:47 AM
	Keytruda monotherapy-vs-placebo DFS HR=0.76 in adjuvant* NSCLC, irrespective		DewDiligence	03/17/22 5:08 PM
	That’s a clerical error.		DewDiligence	03/17/22 9:15 AM
	Upon looking at Merck's Pipeline webpage I see		Just the facts maam	03/17/22 3:51 AM
	COVID SCAM IS OVER... ALL THESE GRIFTER COMPANIES		Agoura Guy	02/11/22 8:23 PM
	MRK 4Q21 CC slides:		DewDiligence	02/03/22 12:39 PM
	MRK 4Q21 results:		DewDiligence	02/03/22 10:41 AM
	BIG PHARMA INCLUDING MERCK IN TROUBLE WITH NEW		Agoura Guy	01/08/22 4:52 PM
	India Won't Add Merck's COVID-19 Pill To National		Agoura Guy	01/06/22 1:04 PM
	BIG PHARMA RELYING UPON FRAUDULENT COVID-19 PCR TESTING		Agoura Guy	01/03/22 12:53 PM
	MERCK IS LATE TO THE PARTY, WITHOUT 94%		Agoura Guy	01/03/22 12:36 PM
	ISN'T IT INTERESTING HOW BIG PHARMA IS TAKING		Agoura Guy	01/03/22 12:31 PM
	FDA grants EUA for MRK’s Molnupiravir—with_a_major_limitation:		DewDiligence	12/23/21 9:54 AM
	Merck’s New Covid Pill Is a Disaster		Stock_Barber	12/18/21 10:12 AM
	Any time I see the term "PCR-confirmed Covid		Stock_Barber	12/18/21 9:55 AM
	A study published this week by researchers at		Lowjack	12/18/21 6:40 AM
	Did anyone else see the news approval in Denmark?		kayoboi	12/16/21 9:54 AM
	Bah... what's a little cancer or a bunch		Stock_Barber	12/14/21 1:46 PM
	NY Times Casually Admits New FDA-Approved Merck COVID		Agoura Guy	12/14/21 1:13 PM
Likes	Subject	Older

Older

DewDiligence

02/02/23 8:10 AM

MRK 4Q22 results—2023 guidance:

DewDiligence

01/27/23 10:25 AM

FDA approves Keytruda for adjuvant NSCLC following adjuvant

extrooper

01/27/23 8:18 AM

That would be the best , most productive

DewDiligence

01/25/23 1:29 PM

Keytruda fails again in prostate cancer—one of the

Pattyloco

12/29/22 10:02 AM

Why

DewDiligence

12/22/22 11:14 AM

The MRK-SGEN deal reputed to be nearly done

DewDiligence

12/13/22 9:59 AM

MRK/MRNA cancer vaccine shines in adjuvant melanoma (RFS HR=0.56):

DewDiligence

11/21/22 8:36 AM

MRK acquires IMGO for $36.00/sh cash—a 107% premium

DewDiligence

11/18/22 3:44 PM

I would take the other side of that bet!

Pattyloco

11/18/22 3:44 PM

Ehhhhh seems a lot more likely today

DewDiligence

11/18/22 3:43 PM

Unlikely, haha.

Pattyloco

11/18/22 3:36 PM

NWBO next purchase of Merck?

DewDiligence

10/27/22 12:26 PM

MRK 3Q22 CC slides:

DewDiligence

10/27/22 9:25 AM

MRK 3Q22 results:

DewDiligence

10/12/22 11:26 AM

MRK exercises option_to_commercialize MRNA cancer vaccine:

DewDiligence

10/10/22 12:23 PM

Sotatercept phase-3 in PAH hits primary endpoint:

DewDiligence

10/06/22 8:28 PM

Lagevrio misses_primary_endpoint_in_large_Oxford_U_trial:

DewDiligence

09/20/22 9:22 AM

FDA allows some Islatravir trials to_resume_at_a lower dose:

DewDiligence

09/10/22 3:00 PM

Keytruda narrowly_misses_statsig OS/PFS as_addend_to Lenvina in_ first-line HCC:

TechandBio

08/18/22 8:37 AM

Merck snatched up ROR1 veslobio for 2.75 Billion

DewDiligence

08/03/22 11:59 AM

Keytruda fails phase-3 in CRPC:

DewDiligence

06/22/22 7:22 AM

FDA approves MRK’s pneumococcal vaccine, Vaxneuvance for infants/children:

Agoura Guy

06/18/22 8:17 PM

WHAT ARE YOU TALKING ABOUT??? COVID-19 IS

Lowjack

06/18/22 7:31 PM

Pay attention, looks like we have a change

DewDiligence

06/07/22 12:15 PM

MRK slides from ASCO webcast:

DewDiligence

05/26/22 6:39 PM

Synopsis of (anti-LAG-3) favezelimab data from ASCO abstract:

DewDiligence

04/28/22 8:54 AM

MRK 1Q22 results:

DewDiligence

04/25/22 10:32 AM

CHMP approves Keytruda/chemo in the neoadjuvant setting followed

DewDiligence

04/14/22 9:59 AM

MRK’s V116—(follow-on_to Vaxneuvance)—receives FDA BTD for prevention of

DewDiligence

04/01/22 10:28 AM

MRK—Vaxneuvance sBLA for pediatrics gets 3-month extension to 7/1/22:

DewDiligence

03/21/22 5:47 PM

FDA approves Keytruda monotherapy for recurrent endometrial cancer

Just the facts maam

03/20/22 6:47 AM

Thanks DewDiligence. The reason I ask, is that

DewDiligence

03/17/22 5:08 PM

Keytruda monotherapy-vs-placebo DFS HR=0.76 in adjuvant* NSCLC, irrespective

DewDiligence

03/17/22 9:15 AM

That’s a clerical error.

Just the facts maam

03/17/22 3:51 AM

Upon looking at Merck's Pipeline webpage I see

Agoura Guy

02/11/22 8:23 PM

COVID SCAM IS OVER... ALL THESE GRIFTER COMPANIES

DewDiligence

02/03/22 12:39 PM

MRK 4Q21 CC slides:

DewDiligence

02/03/22 10:41 AM

MRK 4Q21 results:

Agoura Guy

01/08/22 4:52 PM

BIG PHARMA INCLUDING MERCK IN TROUBLE WITH NEW

Agoura Guy

01/06/22 1:04 PM

India Won't Add Merck's COVID-19 Pill To National

Agoura Guy

01/03/22 12:53 PM

BIG PHARMA RELYING UPON FRAUDULENT COVID-19 PCR TESTING

Agoura Guy

01/03/22 12:36 PM

MERCK IS LATE TO THE PARTY, WITHOUT 94%

Agoura Guy

01/03/22 12:31 PM

ISN'T IT INTERESTING HOW BIG PHARMA IS TAKING

DewDiligence

12/23/21 9:54 AM

FDA grants EUA for MRK’s Molnupiravir—with_a_major_limitation:

Stock_Barber

12/18/21 10:12 AM

Merck’s New Covid Pill Is a Disaster

Stock_Barber

12/18/21 9:55 AM

Any time I see the term "PCR-confirmed Covid

Lowjack

12/18/21 6:40 AM

A study published this week by researchers at

kayoboi

12/16/21 9:54 AM

Did anyone else see the news approval in Denmark?

Stock_Barber

12/14/21 1:46 PM

Bah... what's a little cancer or a bunch

Agoura Guy

12/14/21 1:13 PM

NY Times Casually Admits New FDA-Approved Merck COVID

Older

Merck & Co. Inc. (MRK)

Followers	63	Posters	162
Posts (Today)	0	Posts (Total)	851
Created	07/04/06	Type	Free
Moderators DewDiligence

MRK Investor Relations

Most Liked Posts
(Last 30 Days)

No Liked Posts in the last 30 Days

Volume:
Day Range:
Last Trade Time:

Detailed Quote

MRK Latest News

Amended Statement of Ownership (sc 13g/a) 02/03/2023 04:28:50 PM
Merck’s KEYTRUDA® (pembrolizumab) Plus Chemotherapy Met Primary Endpoint of Progression-Free Survival (PFS) as First-Line Therapy for Advanced or Recurrent Endometrial Carcinoma 02/03/2023 06:45:00 AM
Merck Announces Fourth-Quarter and Full-Year 2022 Financial Results 02/02/2023 06:30:00 AM
FDA Approves KEYTRUDA® (pembrolizumab) as Adjuvant Treatment Following Surgical Resection and Platinum-Based Chemotherapy for Patients With Stage IB (T2a =4 Centimeters), II, or IIIA Non-Small Cell Lung Cancer (NSCLC) 01/27/2023 06:45:00 AM
Merck Animal Health Receives U.S. FDA Approval of Expanded Indication for BRAVECTO (fluralaner) Chews for Dogs 01/26/2023 08:02:00 AM

More MRK News

New Post

Quotes:

IHub:

Quotes:

IHub:

Merck & Co. Inc. (MRK)

Most Liked Posts
(Last 30 Days)

Detailed Quote

Detailed Quote

MRK Latest News

More MRK News

Most Liked Posts
(Last 30 Days)

Quotes:

IHub:

Quotes:

IHub:

Latest Posts

Merck & Co. Inc. (MRK)

Most Liked Posts (Last 30 Days)

MRK Latest News

Most Liked Posts (Last 30 Days)

Most Liked Posts
(Last 30 Days)

Most Liked Posts
(Last 30 Days)